New allergy pill tested: can you skip the water?
NCT ID NCT06284902
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 26 times
Summary
This study tested a new version of the allergy medicine fexofenadine to see how well it enters the bloodstream when taken with or without water, compared to the current coated tablet taken with water. Twenty-five healthy adults participated under fasting conditions. The goal was to measure drug levels, not to treat any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Syneos Health Clinic inc.
Québec, Quebec, G1P 0A2, Canada
Conditions
Explore the condition pages connected to this study.